Not Signed In -
Ofloxacin |
Floxin |
Image:Ofloxacin.png Ofloxacin Systematic (IUPAC) name (+/-)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)- 7-oxo-7H-pyrido [1,2,3-de]-1, 4-benzoxazine-6-carboxylic acid Identifiers CAS number 82419-36-1 ATC code J01MA01 J01MA02, J01MA12, S01AX11, S01AX13, S01AX19, S03AA07 PubChem 4583 DrugBank APRD00502 Chemical data Formula C18H20FN3O4 Mol. weight 361.368 g/mol Pharmacokinetic data Bioavailability ? Protein binding 32% Metabolism ? ...
Wikipedia - [full article]
Ofloxacin Clinical Trials
- Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate
ClinicalTrials.gov Identifier: NCT00480376 - Not yet recruiting
Infection
- Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
- MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
ClinicalTrials.gov Identifier: NCT00563394 - Completed
Diabetic Foot Ulcers
- MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
ClinicalTrials.gov Identifier: NCT00563433 - Completed
Diabetic Foot Ulcers
- A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects with HIV Infection
ClinicalTrials.gov Identifier: NCT00002249 - Completed
HIV Infections
email this page
print this page
bookmark this page
feedback on this page
